Free Trial
NYSE:GRDN

Guardian Pharmacy Services Q3 2026 Earnings Date & Estimates

Guardian Pharmacy Services logo
$40.34 -0.94 (-2.28%)
Closing price 10/12/2026 03:59 PM Eastern
Extended Trading
$40.44 +0.11 (+0.26%)
As of 10/12/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Guardian Pharmacy Services is estimated to report Q3 2026 earnings on Monday, November 9, 2026, after market closes. The conference call is scheduled for 4:30 PM ET.

Upcoming Earnings Announcement

Quarter
Q3 2026
Announcement Date
Time
After Market Closes
Conference Call
4:30 PM ET

What Analysts Expect from Guardian Pharmacy Services in Q3 2026

Guardian Pharmacy Services is expected to post earnings of $0.32 per share on revenue of $365.76 million. In the same quarter a year earlier Guardian Pharmacy Services reported $0.25 per share on revenue of $377.43 million. Guardian Pharmacy Services last reported on August 6, 2026, posting $0.29 per share and beating the $0.2617 consensus estimate. Guardian Pharmacy Services has beaten the consensus EPS estimate in 4 of its last 6 quarters.

Consensus Estimates

Consensus EPS
$0.32
Expected Revenue
$365.76 million
Prior-Year EPS
$0.25
Prior-Year Revenue
$377.43 million
Expected EPS Growth
+28.0%
Expected Revenue Growth
-3.1%

Recent Track Record

Last Reported
Q2 2026
Last Quarter EPS
$0.29 (Beat by +$0.0283)
Last Quarter Revenue
$351.77 million
EPS Beat Rate
4 of last 6 quarters

Guardian Pharmacy Services Q3 2026 Earnings FAQ

Guardian Pharmacy Services (NYSE:GRDN) is estimated to report Q3 2026 earnings on Monday, November 9, 2026, after market closes. This date is estimated from past reporting schedules and may change once the company confirms it.

Guardian Pharmacy Services' Q3 2026 earnings conference call is scheduled for Monday, November 9, 2026 at 4:30 PM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date.

Analysts expect Guardian Pharmacy Services to post earnings of $0.32 per share for Q3 2026.

The consensus revenue estimate for Guardian Pharmacy Services is $365.76 million for Q3 2026.

Guardian Pharmacy Services Earnings Headlines

Guardian Pharmacy Services: Slowing Growth In H2 2026
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and stinging losses? Dave Aquino is giving away the exact 11-hour options strategy he uses in volatile markets. You get the plain English blueprint behind the strategy and the very same "rinse and repeat" ticker he's traded nearly 900 times with a 95.3% success rate. It's so simple to understand, you could trade it tomorrow.tc pixel
See More Guardian Pharmacy Services Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Guardian Pharmacy Services? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Guardian Pharmacy Services and other key companies, straight to your email.

About Guardian Pharmacy Services

Guardian Pharmacy Services (NYSE:GRDN) (NYSE: GRDN) is a healthcare services company that provides pharmacy services to residents of long-term care and other institutional healthcare settings. Its customers include assisted living communities, skilled nursing facilities, behavioral health centers and communities serving individuals with developmental disabilities.

The company’s services include prescription dispensing, medication packaging and delivery, medication management, pharmacy consulting and clinical support. Guardian works with healthcare providers and facility staff to help coordinate residents’ medication regimens, support adherence and meet the operational requirements of institutional care.

Guardian Pharmacy Services operates through a network of pharmacies serving communities in multiple regions of the United States. The company was established to provide specialized pharmacy infrastructure for long-term care providers, combining local pharmacy operations with centralized resources and technology. Fred Burke serves as the company’s chief executive officer.

View Guardian Pharmacy Services Profile